 effect cisaprid patient cystic fibrosi distal intestin obstruct syndrom double-blind placebo-control crossov trial effect prokinet drug cisaprid patient cystic fibrosi chronic recurr distal intestin obstruct syndrom dio baselin period patient year boy random order cisaprid mg time mouth month gastrointestin symptom flatul abdomin pain full abdomin distens nausea anorexia heartburn diarrhea regurgit time monthli physic examin baselin period assess food intak day stool collect pulmonari function test abdomin radiograph cisaprid therapi placebo signific reduct flatul full nausea patient symptom score cisaprid cisaprid patient physician patient side effect signific differ cisaprid placebo period nutrit statu x-ray score pulmonari function food intak fat protein calori stool size consist fecal loss fat bile acid chymotrypsin calori acut episod dio intestin lavag time patient treatment cisaprid time patient placebo comparison unselect patient cystic fibrosi pancreat insuffici enzym supplement distal intestin obstruct fecal fat loss percentag intak high studi group dio vs dosag long-term treatment cisaprid chronic abdomin symptom patient cystic fibrosi dio need intestin lavag cisaprid treatment effect digest nutrit statu cystic fibrosi patient pancreat insuffici